Anti-Aβ42– and anti-Aβ40–specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model
J. Clin. Invest. Yona Levites, et al. 116:193
doi:10.1172/JCI25410 [Go to this article.]

Problems with a PDF?